ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Scope & Guideline
Advancing the Future of Gastrointestinal Health
Introduction
Aims and Scopes
- Gastrointestinal and Liver Disease Research:
The journal covers a wide array of gastrointestinal and liver diseases, highlighting research on pathophysiology, diagnosis, and treatment options. - Pharmacotherapy and Treatment Strategies:
AP&T emphasizes the role of pharmacotherapy in managing gastrointestinal and liver diseases, including studies on drug efficacy, safety, and guidelines for clinical practice. - Emerging Therapies and Interventions:
The journal frequently publishes research on novel treatment modalities, including biologics, small molecules, and innovative therapies for various digestive disorders. - Clinical Guidelines and Best Practices:
AP&T aims to provide evidence-based recommendations for clinicians, focusing on improving patient outcomes in gastrointestinal and liver diseases. - Patient-Centered Outcomes and Quality of Life:
The journal addresses the importance of patient-reported outcomes, quality of life, and the psychosocial aspects of managing chronic digestive diseases. - Epidemiological Studies and Public Health:
Research related to the epidemiology of gastrointestinal and liver diseases, including risk factors, prevalence, and the impact of public health initiatives, is a key focus area. - Technology and Innovation in Gastroenterology:
AP&T explores advancements in diagnostic and therapeutic technologies, including the use of machine learning and non-invasive testing methods in gastroenterology.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on MAFLD is increasingly prominent, focusing on its clinical implications, pathophysiology, and treatment strategies, reflecting a growing recognition of its significance. - Biologics and Targeted Therapies:
The use of biologics and targeted therapies for inflammatory bowel disease (IBD) and other gastrointestinal conditions is a rapidly expanding area of research, with a focus on optimizing treatment regimens. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting disease outcomes and personalizing treatment approaches is a growing trend, indicating a shift towards data-driven medicine. - Patient-Centered Care and Quality of Life:
There is an increasing emphasis on research that evaluates patient-reported outcomes and quality of life in the context of gastrointestinal diseases, aligning with broader trends in healthcare. - Public Health and Epidemiology:
Studies addressing the epidemiology of liver diseases and gastrointestinal disorders, as well as public health interventions, are gaining traction, reflecting an awareness of the societal impact of these conditions. - Gut Microbiome Research:
The exploration of the gut microbiome’s role in health and disease, particularly in IBD and liver diseases, is an emerging theme, highlighting its significance in therapeutic strategies. - Long-term Outcomes of Chronic Diseases:
Research focusing on the long-term outcomes of chronic gastrointestinal and liver diseases, including the impact of treatment on disease progression and survival, is becoming increasingly important.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for gastrointestinal diseases has seen reduced emphasis, as newer therapies and pharmacological approaches gain prominence. - Basic Science without Clinical Relevance:
Studies that do not translate into clinical applications or lack direct relevance to patient care are being published less frequently, as the journal prioritizes clinically impactful research. - Single-Center Studies:
There is a noticeable decline in the publication of single-center studies, with a shift towards multi-center and larger cohort studies that yield more generalizable results. - Isolated Pathophysiological Mechanisms:
Research focusing solely on isolated mechanisms of disease without exploring therapeutic implications or clinical outcomes is diminishing, reflecting a preference for integrated approaches. - Non-Pharmacological Treatments:
There appears to be a waning interest in non-pharmacological treatments for digestive diseases, as the journal increasingly emphasizes pharmacotherapy and innovative drug treatments.
Similar Journals
JOURNAL OF NEPHROLOGY
Elevating nephrology knowledge for a healthier future.JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.
Gastroenterology Insights
Fostering Collaboration in Gastrointestinal ResearchGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
Gastroenterology
Elevating Knowledge in Gastroenterology and HepatologyGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
Gastroenterology Research
Delivering impactful research to the global gastroenterology community.Gastroenterology Research is a prominent scholarly journal dedicated to advancing the field of gastroenterology. Published by ELMER PRESS INC, this journal serves as a vital platform for disseminating innovative research, clinical findings, and comprehensive reviews that explore the complexities of the gastrointestinal system. With an ISSN of 1918-2805 and an E-ISSN of 1918-2813, it reaches a global audience of researchers, healthcare professionals, and students eager to contribute to or keep abreast of the latest developments in gastroenterology. Though details such as the H-index and Scopus rankings are currently unspecified, the journal's commitment to quality and impact in the medical research community is evident. Gastroenterology Research aims to foster collaboration and knowledge sharing among experts, ultimately improving patient care and outcomes within this critical area of health science. Explore the cutting-edge studies published within its pages and engage with a community passionate about the investigation and treatment of gastrointestinal diseases.
PULMONARY PHARMACOLOGY & THERAPEUTICS
Empowering professionals with vital pulmonary research.Welcome to Pulmonary Pharmacology & Therapeutics, a leading journal dedicated to the dissemination of innovative research and insights in the fields of pulmonary medicine and pharmacology. Published by Academic Press Ltd - Elsevier Science Ltd, this journal has made significant contributions to the academic community since its inception in 1997, with an ongoing commitment to relevant advancements projected through to 2024. With reputable Q2 rankings across vital categories including Biochemistry (medical), Medicine (miscellaneous), Pharmacology (medical), and Pulmonary and Respiratory Medicine, Pulmonary Pharmacology & Therapeutics is ranked in the top tier of its field, reflecting its impact on the discipline as evidenced by its Scopus rankings. Researchers, healthcare professionals, and students alike can access a wealth of high-quality articles that address the complexity of pulmonary diseases and therapeutic strategies, supporting research and clinical practice alike. Join the vibrant community contributing to this essential field and explore the latest findings that can drive change in patient care and therapeutic effectiveness.
Korean Journal of Gastroenterology
Exploring Innovations in GastroenterologyKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
Gastroenterology Review-Przeglad Gastroenterologiczny
Bridging Research and Practice in GastroenterologyGastroenterology Review-Przeglad Gastroenterologiczny is a premier, peer-reviewed journal published by TERMEDIA PUBLISHING HOUSE LTD, focusing on the dynamic field of gastroenterology. Since its inception in 2006, it has embraced an Open Access model, ensuring that the latest research is readily accessible to a global audience, fostering collaboration and innovation. Based in Poland, this journal serves as a crucial platform for disseminating significant findings in gastrointestinal research, with a current Scopus rank placing it at the 39th percentile in its category. With a commitment to advancing the understanding of gastroenterological conditions, *Gastroenterology Review* publishes original articles, reviews, and case studies that contribute to both clinical practice and academic research. The journal is particularly aimed at researchers, healthcare professionals, and students who ignite dialogues that shape the future of gastrointestinal health. Explore the comprehensive insights that this journal offers, as it encapsulates vital developments from 2008 to 2024 in the ever-evolving landscape of gastroenterology.
Canadian Journal of Gastroenterology and Hepatology
Championing Excellence in Gastroenterology and HepatologyCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
ZEITSCHRIFT FUR GASTROENTEROLOGIE
Navigating the Future of Gastrointestinal Medicine TogetherZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Connecting researchers and clinicians for better outcomes.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.